Final common pathways of progression of renal diseases
スポンサーリンク
概要
- 論文の詳細を見る
- 2002-12-01
著者
関連論文
- Drug Discovery for Overcoming Chronic Kidney Disease (CKD) : Prolyl-Hydroxylase Inhibitors to Activate Hypoxia-Inducible Factor (HIF) as a Novel Therapeutic Approach in CKD
- Pathophysiological Response to Hypoxia — From the Molecular Mechanisms of Malady to Drug Discovery:Epigenetic Regulation of the Hypoxic Response via Hypoxia-Inducible Factor and Histone Modifying Enzymes
- evidence-based practice guideline for the treatment of chronic kidney disease
- Pathogenesis and prognosis of thrombotic microangiopathy
- Captopril renography in Bartter's syndrome
- Activation of the Renin-Angiotensin System and Chronic Hypoxia of the Kidney
- Mesangial cell-predominant functional gene, megsin
- Mechanisms of immune-deposit formation and the mediation of immune renal injury
- Final common pathways of progression of renal diseases
- Pathophysiological Response to Hypoxia-From the Molecular Mechanisms of Malady to Drug Discovery : Epigenetic Regulation of the Hypoxic Response via Hypoxia-Inducible Factor and Histone Modifying Enzymes
- Mechanisms of Tubulointerstitial Injury in the Kidney : Final Common Pathways to End-stage Renal Failure